Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas

The biological properties of CCN proteins include stimulation of cell proliferation, migration, and adhesion, as well as angiogenesis and tumorigenesis. We quantified CYR61, CTGF, WISP-1, and NOV mRNA expression levels in samples from sixty-six primary gliomas and five normal brain samples using quantitative real-time PCR assay. Statistical analysis was performed to explore the links between expression of the CCN genes and clinical and pathological parameters. Overexpression of CYR61, CTGF, WISP-1, and NOV occurred in 48% (32 of 66), 58% (38 of 66), 36% (24 of 66), and 15% (10 of 66) of primary gliomas, respectively. Interestingly, significant associations were found between CYR61 expression versus tumor grade, pathology, gender, and age at diagnosis. Also, a significant correlation existed between CTGF mRNA levels versus tumor grade, gender, and pathology. In contrast to CYR61 and CTGF, no significant association was found between expression of either WISP-1 or NOV versus any of the pathological features. Furthermore, Cox regression analysis showed that CYR61 and CTGF expression had a significant correlation with patient survival. These results suggest that CYR61 and CTGF may play a role in the progression of gliomas; their levels at diagnosis may have prognostic significance; and these proteins might serve as valuable targets for therapeutic intervention.

[1]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[2]  L. Lau,et al.  Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. , 1985, The EMBO journal.

[3]  Kakinuma,et al.  Expression of fibrogenic cytokines in desmoplastic malignant melanoma , 1998, The British journal of dermatology.

[4]  P. A. Harding,et al.  Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. , 1998, Growth factors.

[5]  L. Lau,et al.  Adhesion of Human Umbilical Vein Endothelial Cells to the Immediate-Early Gene Product Cyr61 Is Mediated through Integrin αvβ3 * , 1998, The Journal of Biological Chemistry.

[6]  M. Takigawa,et al.  Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. , 1998, Journal of biochemistry.

[7]  E. Wilson,et al.  Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. , 1998, The Journal of clinical endocrinology and metabolism.

[8]  Gary R. Grotendorst,et al.  Connective Tissue Growth Factor Expression in Pediatric Myofibroblastic Tumors , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[9]  J. Yokota,et al.  Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. , 1996, Cancer research.

[10]  J. Lakins,et al.  Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. , 2000, Cancer research.

[11]  H. Hanafusa,et al.  Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src , 1996, Molecular and cellular biology.

[12]  T. Matsumura,et al.  Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. , 1999, Journal of biochemistry.

[13]  B. Perbal.  The CCN family of genes: a brief history , 2001, Molecular pathology : MP.

[14]  R. Elashoff,et al.  Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. , 2001, Cancer research.

[15]  Gary R. Grotendorst,et al.  Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. , 1993, Molecular biology of the cell.

[16]  N. M. Khazenzon,et al.  Gene expression abnormalities in human glial tumors identified by gene array. , 2001, International journal of oncology.

[17]  V. Joliot,et al.  Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas , 1992, Molecular and cellular biology.

[18]  R. Weichselbaum,et al.  Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV) , 2001, Molecular pathology : MP.

[19]  D. Brigstock.  The Connective Tissue Growth Factor/cysteine- Rich 61/nephroblastoma Overexpressed (ccn) Family* , 2022 .

[20]  L. Lau,et al.  The CCN family of angiogenic regulators: the integrin connection. , 1999, Experimental cell research.

[21]  M. Mattei,et al.  Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  O. Kallioniemi,et al.  Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. , 2000, Cancer research.

[23]  L. Lau,et al.  Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin αvβ3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo , 1999, Molecular and Cellular Biology.

[24]  David E. Misek,et al.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. , 2001, Cancer research.

[25]  A. Brunner,et al.  Identification of a gene family regulated by transforming growth factor-beta. , 1991, DNA and cell biology.

[26]  Gordon Mills,et al.  Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC , 1998, Current Biology.

[27]  R. Winneker,et al.  Cyr61, a Member of the CCN Family, Is Required for MCF-7 Cell Proliferation: Regulation by 17β-Estradiol and Overexpression in Human Breast Cancer. , 2001, Endocrinology.

[28]  Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements. , 2000, Neuro-oncology.

[29]  P. Bork.  The modular architecture of a new family of growth regulators related to connective tissue growth factor , 1993, FEBS letters.

[30]  D. Botstein,et al.  WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Wex,et al.  CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL) , 2000, British Journal of Cancer.

[32]  E. Viégas-Péquignot,et al.  Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. , 1997, Molecular pathology : MP.

[33]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[34]  W. Cavenee,et al.  Accumulation of genetic defects during astrocytoma progression , 1992, Cancer.

[35]  R. Coffey,et al.  Identification of rCop-1, a New Member of the CCN Protein Family, as a Negative Regulator for Cell Transformation , 1998, Molecular and Cellular Biology.

[36]  H. Hameister,et al.  Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells , 1999, Oncogene.

[37]  A. Levine,et al.  WISP-1 is a Wnt-1- and β-catenin-responsive oncogene , 2000, Genes & Development.

[38]  Gary R. Grotendorst,et al.  Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. , 1997, The international journal of biochemistry & cell biology.